A detailed history of Salomon & Ludwin, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Salomon & Ludwin, LLC holds 272 shares of DXCM stock, worth $15,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
272
Previous 204 33.33%
Holding current value
$15,792
Previous $17,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$66.46 - $89.53 $4,519 - $6,088
68 Added 33.33%
272 $18,000
Q2 2025

Jul 29, 2025

BUY
$59.83 - $87.57 $9,572 - $14,011
160 Added 363.64%
204 $17,000
Q3 2024

Oct 24, 2024

BUY
$64.0 - $116.06 $2,816 - $5,106
44 New
44 $2,000
Q2 2020

Jul 17, 2020

SELL
$62.68 - $105.34 $8,148 - $13,694
-130 Closed
0 $0
Q1 2020

Apr 03, 2020

BUY
$47.79 - $75.63 $6,212 - $9,831
130 New
130 $35,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Salomon & Ludwin, LLC Portfolio

Follow Salomon & Ludwin, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salomon & Ludwin, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salomon & Ludwin, LLC with notifications on news.